Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

Merck Sharp & Dohme Corp has been awarded a Texas contract (HHSTX-6-0000407459) effective June 23, 2026, to provide pricing for childhood vaccines under the authority of Texas Government Code Section 2155.144. The contract references the current Centers for Disease Control and Prevention Federal Contract for Vaccine and Biologicals (CDC Federal Contract Number: 75D30126D20729) and is procured for the benefit of clients served by Texas Health and Human Services programs. The vaccine products encompassed by this award include rubella virus vaccine, diphtheria and tetanus toxoids absorbed, tetanus vaccine, and tiprotimod, with classification under serums, toxoids, and vaccines (NIGP Code 26980).

The contract establishes a framework for vaccine acquisition by the State of Texas to support public health immunization initiatives. Specific contract duration, annual value, and cumulative contract amount were not disclosed in the award documentation. The procurement was executed pursuant to Texas Government Code Section 771, which authorizes the acquisition of goods and services for state agency programs. As the prime contractor and original vaccine manufacturer, Merck Sharp & Dohme Corp will serve as the sole source provider under this statewide pricing agreement aligned with federal vaccine procurement standards.